| Epigentek Poised to Become Most Influential Epigenetic Player in Chromatin Immunoprecipitation (ChIP) Market Published 04/13/2015 |
|||
 |
|||
| Epigentek, a biotech firm based in Farmingdale, New York, now offers epigenetic researchers the most comprehensive selection of convenient tools for conducting accurate chromatin immunoprecipitation (ChIP) experiments. Since 2005, Epigentek has been helping investigators carry out high quality, affordable, and publishable epigenetic research with their wide range of kits, antibodies, reagents, and instruments. Now, Epigentek has established their expansive repertoire of optimized ChIP products and services with the recent addition of two ChIP kits that focus on low cell input and streamlining ChIP-seq projects, thereby securing their position as a promising influential player in the chromatin immunoprecipitation (ChIP) market. Chromatin immunoprecipitation is one of the most popular assays in epigenetic research used to investigate protein-DNA interactions in cells. In light of advancements in next-generation sequencing (NGS) technology, ChIP-seq can also be used in conjunction with chromatin IP to pinpoint a specific gene sequence to which a protein of interest binds on a significantly wider scale, helping investigators understand crucial cellular processes. The company’s complete solutions for chromatin immunoprecipitation draws on over a decade of experience in epigenetic research and address a variety of demands and needs familiar to many researchers. Ranging from an extensive line of convenient microplate-based ChIP kits to comprehensive chromatin immunoprecipitation sequencing (ChIP-seq) and ChIP-qPCR services, Epigentek offers innovative and effective solutions for every step of a ChIP workflow. After they debuted the first microplate-based ChIP format in 2005, the team at Epigentek resolved the throughput bottleneck that had long been hindering scientists’ ChIP experiments. Similarly, their 96-well plate based Pre-Sure™ kit for ChIP antibody validation, introduced in 2014, overcame issues many researchers face in regard to the highly variable and unreliable so-called “ChIP-grade” antibodies that saturate the market. Due to Epigentek’s proprietary method, researchers now quickly validate their antibodies for ChIP without having to carry out cumbersome ChIP-PCR or full-blown ChIP sequencing. The growing biotech company continues to refine their epigenetic expertise with their extensive line of ChIP research kits that brings convenient, easy-to-use, and accurate tools to the lab. The company’s full line of microplate-based ChIP kits are specifically designed by a team of in-house scientists to overcome common demands and limitations faced by nearly all researchers, such as low cell numbers, turnaround time, and high throughput, next-generation sequencing compatibility. These ChIP kits use a convenient microplate-based format and are built specifically for low cell input, tissue input, plant input, or even all-in-one ChIP-seq library preparation. Epigentek’s highly-cited classic ChIP kit for cell input is available to researchers looking to perform ChIP accurately, at rapid speeds, and with extraordinary consistency. The EpiQuik Chromatin Immunoprecipitation (ChIP) Kit uses a flexible microwell strip format and comes with a convenient bundle of ready-to-use essential components. This chromatin immunoprecipitation kit is suitable in combination with qualitative and quantitative PCR (qPCR), methylation specific PCR (MS-PCR), DNA sequencing, southern blot, and DNA microarray. Optimized for researchers facing limitations with low cell numbers, the recently released ChromaFlash High-Sensitivity ChIP Kit enables scientists to perform high-throughput ChIP in a convenient microplate-based format using as few as 2,000 cells. The EpiQuik Tissue Chromatin Immunoprecipitation (ChIP) Kit is created specifically for researchers working with mammalian tissue input. For those using plant cells, the EpiQuik Plant ChIP Kit is made precisely for carrying out a successful chromatin immunoprecipitation from plant cells. The EpiNext ChIP-Seq High-Sensitivity Kit (Illumina) expedites NGS-based experiments from start to finish for seamless integration into a researcher’s ChIP-seq workflow. This ChIP kit is first of its kind to conveniently package ChIP and ChIP-seq library preparation into one easy-to-use kit. Adding to their repertoire of chromatin immunoprecipitation research tools, the company has also advanced DNA shearing and chromatin shearing technology with their high throughput line of sonication systems, including the multi-sample EpiSonic 2000 which enables researchers to consistently and reliably shear up to 12 samples to 300 bp in only 10 minutes. Furthermore, Epigentek recently announced their chromatin analysis services including ChIP antibody validation, chromatin immunoprecipitation sequencing (ChIP-seq) and chromatin immunoprecipitation quantitative PCR (ChIP-qPCR) to provide researchers with accurate, publication-ready results. Epigentek’s years of experience and their continued innovation in ChIP kit products and services over the past decade, including the recent addition of their high sensitivity ChIP and ChIP-seq kits, make this company poised to become one of the most influential players in the ChIP market. For a comparison of all ChIP kits offered, readers can visit http://www.epigentek.com/chip About Epigentek Group Inc. Epigentek is a New York-based biotechnology company that focuses on developing and providing innovative technologies, services, and products as a complete and systematic solution for epigenetic related research and drug discovery. Visit the informative website at http://www.epigentek.com. |
|||
|
|||
| Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpigenTek Group Inc. All rights reserved. |
Cart (0)
